Literature DB >> 15737284

[Time trends and geographical variations in the prevalence of symptoms of allergic rhinitis in 6-7-year-old children from eight areas of Spain according to the ISAAC].

A Arnedo-Pena1, L García-Marcos, G García Hernández, I Aguinagua Ontoso, C González Díaz, M Morales Suárez-Varela, B Domínguez Aurrecoechea, R Busquets Monge, A Blanco Quiros, J Batlles Garrido, I Miner Kanflanka, A López-Silvarrey Varela.   

Abstract

BACKGROUND: Phase III of the International Study of Asthma and other Allergies in Childhood (ISAAC) was carried out in schoolchildren aged 6-7 years from eight areas of Spain to estimate time trends and geographic variations in the prevalence of symptoms of allergic rhinitis (AR). MATERIAL AND
METHOD: A standard and validated questionnaire was used following ISAAC methodology and was completed by the schoolchildren's parents. The prevalence of symptoms of AR in Phase I (1993-1994) and Phase III (2001-2002) was compared. Eight centers participated: Asturias, Barcelona, Bilbao, Cartagena, Castellón, Madrid, Pamplona and Valencia. Poisson regression was used in the analysis.
RESULTS: A total of 25,113 schoolchildren were studied with a median participation of 81.7 %. In all centers, AR symptoms tended to increase, with a prevalence ratio of rhinoconjunctivitis in the previous year of 1.61 (95 % confidence interval: 1.48-1.76) when both phases, adjusted by gender, center, and seasonal variation, were compared. The prevalence of AR symptoms was higher in boys than in girls. Wide variations in the prevalence of AR were observed across centers with a higher prevalence in Asturias, Madrid, Cartagena and Bilbao. Lower prevalences were reported in Barcelona, Castellón and Pamplona.
CONCLUSIONS: There seems to have been a general increase in AR symptoms. Substantial variations between centers suggested that there may be local differences in risk factors. Intense research will be required for satisfactory preventive actions.

Entities:  

Mesh:

Year:  2005        PMID: 15737284     DOI: 10.1157/13071837

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  6 in total

1.  Evaluation of The Safety and Efficacy of Newly Developed Domestic Allergenic Extracts for Skin Prick Testing.

Authors:  Mohammad Fereidouni; Roya Mahdavi; Sarah Mahmoudzade; Hadis Rezapoor; Alireza Fereidouni; Afsane Bahrami
Journal:  Rep Biochem Mol Biol       Date:  2021-07

2.  Climate and prevalence of atopic eczema in 6- to 7-year-old school children in Spain. ISAAC phase III.

Authors:  María Morales Suárez-Varela; Luís García-Marcos Alvarez; Michael D Kogan; Agustín Llopis González; Antonio Martínez Gimeno; Inés Aguinaga Ontoso; Carlos González Díaz; Alberto Arnedo Pena; Begoña Domínguez Aurrecoechea; Rosa María Busquets Monge; Alfredo Blanco Quiros; José Batlles Garrido; Iñaqui Miner Canflanca; Angel López-Silvarrey Varela
Journal:  Int J Biometeorol       Date:  2008-09-09       Impact factor: 3.787

3.  Allergens Prevalence among Patients with Respiratory Allergies in Mashhad, Iran.

Authors:  Payam Payandeh; Javad Fadaee; Farahzad Jabbari Azad; Mehdi Bakhshaii; Samane Sistani
Journal:  Tanaffos       Date:  2019-02

4.  Prevalence and risk factors associated with allergic rhinitis in Mexican school children: Global Asthma Network Phase I.

Authors:  Roberto García-Almaraz; Nayely Reyes-Noriega; Blanca Estela Del-Río-Navarro; Arturo Berber; Elsy Maureen Navarrete-Rodríguez; Philippa Ellwood; Luis García Marcos Álvarez
Journal:  World Allergy Organ J       Date:  2020-12-05       Impact factor: 4.084

5.  Asthma in Mexican school-age children is not associated with passive smoking or obesity.

Authors:  Martín Bedolla-Barajas; Ana T Barrera-Zepeda; Juan B López-Zaldo; Jaime Morales-Romero
Journal:  Asia Pac Allergy       Date:  2013-01-22

6.  Prevalence and Risk Factors of Allergic Rhinitis in Primary School Students of Isfahan, Iran.

Authors:  Sahar Salarnia; Tooba Momen; Mohsen Jari
Journal:  Adv Biomed Res       Date:  2018-12-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.